8. ADVERSE EVENT REPORTING 8.1. Adverse Events During each study visit the study clinician will assess AEs which may have occurred since the previous visit. ART toxicities and opportunistic infections will be entered in the electronic medical records as per standard of care, as well as other outcomes (e.g: death, hospitalization).